SEC Form 4 · accession 0001652252-18-000091
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Annette Tumolo
Officer — Executive Vice President
Period of report
Dec 11, 2018
Accepted (ET)
Dec 12, 2018 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Dec 11, 2018 | S | 1,176 | $254.00 | D | 1,504 | D | |
| Bio-Rad A Common Stock | Dec 11, 2018 | M | 1,200 | $159.32 | A | 2,704 | D | |
| Bio-Rad A Common Stock | Dec 11, 2018 | S | 1,200 | $255.00 | D | 1,504 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $159.32 | Dec 11, 2018 | M | 1,200 | D | — | Sep 7, 2026 | Bio-Rad A Common Stock | 1,200 | 1,800 | D |
Explanation of responses
- F1The option vests in five equal annual installments beginning September 7, 2017